Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. China
  4. Shenzhen Stock Exchange
  5. Baolingbao Biology Co.,Ltd.
  6. News
  7. Summary
    002286   CNE100000FL1

BAOLINGBAO BIOLOGY CO.,LTD.

(002286)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Baolingbao Biology Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021

08/19/2021 | 03:52am EDT

Baolingbao Biology Co.,Ltd. announced earnings results for the half year ended June 30, 2021. For the half year, the company announced sales was CNY 1,261.506 million compared to CNY 1,016.516 million a year ago. Operating income was CNY 76.366 million compared to CNY 50.830 million a year ago. Net income was CNY 64.545 million compared to CNY 43.393 million a year ago. Basic earnings per share from continuing operations was CNY 0.17 compared to CNY 0.12 a year ago.


ę S&P Capital IQ 2021
All news about BAOLINGBAO BIOLOGY CO.,LTD.
08/19Baolingbao Biology Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2..
CI
07/13Baolingbao Biology Co.,Ltd. announced that it expects to receive CNY 711.9 million in f..
CI
05/26Baolingbao Biology Co.,Ltd. Announces Cash Dividend of A Shares for the Year 2020, Paym..
CI
05/24Baolingbao Biology Co.,Ltd. Approves Cash Dividend for 2020
CI
04/29Baolingbao Biology Co.,Ltd. Proposes Final Cash Dividend for the Year 2020
CI
04/28Baolingbao Biology Co.,Ltd. Reports Earnings Results for the First Quarter Ended March ..
CI
03/16Baolingbao Biology Co.,Ltd. Approves the Board and Management Elections
CI
02/18Gao Yanming completed the acquisition of 6.8% in Baolingbao Biology Co.,Ltd. from Liu Z..
CI
01/28Gao Yanming signed an agreement to acquire 6.8% in Baolingbao Biology Co.,Ltd. from Liu..
CI
01/28Beijing Yongyu Investment Management Co., Ltd. cancelled the acquisition of additional ..
CI
More news
Financials
Sales 2021 2 534 M 394 M 394 M
Net income 2021 173 M 26,9 M 26,9 M
Net Debt 2021 - - -
P/E ratio 2021 30,8x
Yield 2021 -
Capitalization 5 280 M 821 M 821 M
Capi. / Sales 2021 2,08x
Capi. / Sales 2022 1,74x
Nbr of Employees 1 122
Free-Float 58,9%
Chart BAOLINGBAO BIOLOGY CO.,LTD.
Duration : Period :
Baolingbao Biology Co.,Ltd. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends BAOLINGBAO BIOLOGY CO.,LTD.
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 2
Last Close Price 14,30 CNY
Average target price 20,78 CNY
Spread / Average Target 45,3%
EPS Revisions
Managers and Directors
Yan Jun Wang Chief Financial Officer & Deputy General Manager
Shu Fen Deng Chairman
Hua Xiao Xiao Chairman-Supervisory Board
Yu Hai Su Independent Director
Xin Rong Zhang Independent Director
Sector and Competitors
1st jan.Capi. (M$)
BAOLINGBAO BIOLOGY CO.,LTD.25.44%821
SÜDZUCKER AG15.25%3 185
COSUMAR SA30.58%2 863
SÃO MARTINHO S.A.37.94%2 471
ADECOAGRO S.A.31.32%1 039
BALRAMPUR CHINI MILLS LIMITED119.60%1 029